RxDoctor Payments Data

Preston Wilson, DO

Family Medicine · West Jordan, UTNPI 1952538605

Payments from drug & device makers

$12,665in general payments, 2019–2025

Across 804 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • AstraZeneca$988
  • Pfizer$783
  • Astellas Pharma US Inc$714
  • Novo Nordisk$699
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$12,657100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)109$1,664
Amgen76$1,159
AstraZeneca66$988
Pfizer59$783
Astellas Pharma US Inc41$714
Novo Nordisk53$699
GSK45$683
Lilly USA, LLC41$615
Merck35$454
Boehringer Ingelheim21$441
Gilead19$335
Johnson & Johnson15$309
Axsome Therapeutics, Inc.12$225
Bayer12$202
Viiv Healthcare Company9$201
E.r. Squibb & Sons, L.L.C.11$178
Sanofi-aventis U.S. LLC12$170
Takeda Pharmaceuticals U.S.A., Inc.8$162
Mylan Specialty L.p.8$144
Boston Scientific8$133
Sunovion Pharmaceuticals Inc.9$128
Exact Sciences8$127
Biohaven Pharmaceuticals, Inc.6$118
Vanda Pharmaceuticals Inc.5$94
Jazz Pharmaceuticals Inc.6$91
Dynavax Technologies Corporation6$90
Cranial Technologies, Inc5$86
Idorsia Pharmaceuticals US Inc4$81
Amarin Pharma, Inc.4$79
Organon5$77
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$75
Grifols USA, LLC3$71
Inspire Medical Systems, Inc.3$70
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$68
Harmony Biosciences LLC4$67
Genentech USA, Inc.4$65
Impel Pharmaceuticals Inc.4$65
Abbott3$65
Lucid Diagnostics Inc.4$59
Kowa Pharmaceuticals America, Inc.4$56
Hologic Sales And Service, LLC3$54
Novartis3$53
Supernus Pharmaceuticals, Inc.4$53
Otsuka America Pharmaceutical, Inc.2$51
Corium, LLC4$50
Biohaven Pharmaceutical Holding Company Ltd.4$49
Antares Pharma, Inc.3$40
Edwards Lifesciences1$37
Lundbeck LLC2$36
Corcept Therapeutics2$35
Halozyme Inc2$32
Medtronic1$26
Tris Pharma Inc1$24
Eisai Inc.2$23
Exeltis, USA Inc.1$21
RGH Enterprises LLC1$20
Upsher-smith Laboratories LLC1$17
Dexcom, Inc.1$17
Ironshore Pharmaceuticals Inc.1$16
Shire North American Group Inc1$16

How this compares

$12,665 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$62,587
Medicare patients
206
Services billed
822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$85,366
EliquisApixaban78$80,133
MounjaroTirzepatide41$51,228
OzempicSemaglutide30$43,457
XareltoRivaroxaban41$36,939
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$34,828
FarxigaDapagliflozin Propanediol15$20,174
JanuviaSitagliptin Phosphate14$17,636
Tresiba Flextouch U-200Insulin Degludec14$13,705
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,451
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$6,526
Breo ElliptaFluticasone/Vilanterol11$5,186
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$5,125
Omeprazole302$4,865
Albuterol Sulfate HfaAlbuterol Sulfate132$4,402

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$441$85,36656 claims
PfizerEliquis$783$80,13378 claims
Lilly USA, LLCMounjaro$615$51,22841 claims
Novo NordiskOzempic$699$43,45730 claims
GSKTrelegy Ellipta, Breo Ellipta$683$40,01454 claims
Johnson & JohnsonXarelto$309$36,93941 claims
AstraZenecaFarxiga, Breztri Aerosphere$988$30,62526 claims
MerckJanuvia$454$17,63614 claims
Sanofi-aventis U.S. LLCLantus$170$2,54911 claims
AbbVieSynthroid$1,664$1,38123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 928 family medicine providers in Utah.

Other family medicine in West Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →